Natural killer activity in stage III and IV endometriosis
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 9 (2) , 125-130
- https://doi.org/10.3109/09513599509160201
Abstract
Our objective was to investigate the role of estrogens in the development and progression of endometriosis, and evaluate the in vitro boosting effect of lymphokines on the activity of natural killer cells from endometriosis patients, with respect to the estradiol concentrations. Natural killer activity of peripheral blood was evaluated in 42 endometriosis patients who underwent laparoscopy for pelvic pain, infertility and benign adnexal masses, and it was correlated with serum estradiol levels. Twenty-five women with moderate and severe disease were re-evaluated for immune and endocrine parameters 4–8 weeks after surgery, before any specific adjuvant medical treatment, and analyzed for in vitro responsiveness of cytotoxic cells to interferon (IFN) α2β and interleukin-2 (IL-2) incubation. Patients with moderate and severe endometriosis showed a significant decrease of natural cytotoxicity when compared with patients with mild and minimal disease (p = 0.01). The decrease of immune reactivity was independent of a reduced representation of natural killer cells, and persisted after surgical removal of all macroscopic endometriosis foci. A significant inverse relationship was observed between natural killer activity and serum estradiol levels, which resulted in moderate and severe disease (r = –0.4, p = 0.009) but not in stages I and II. The in vitro responsiveness of cytotoxic cells to lymphokine incubation was preserved; both IFN α2β and IL-2 were able to increase the cytotoxicity of natural killer cells significantly from advanced-stage patients (p, = 0.014 and p = 0.006 for IFN α2β and IL-2, respectively). No relationship was observed between in vitro responsiveness of cytotoxic cells to lymphokine incubation and serum estradiol levels. We conclude that immunoendocrine modulation is important in the development and progression of endometriosis, as suggested by the strict relationship between natural killer activity and serum estradiol levels in advanced stage disease. A primitive, intrinsic defect of immune reactivity seems to be excluded by the preserved in vitro responsiveness of cytotoxic cells to lymphokine incubation.Keywords
This publication has 18 references indexed in Scilit:
- Natural Killer Cell Activity and Progression-Free Survival in Ovarian CancerGynecologic and Obstetric Investigation, 1993
- Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assayJournal of Immunological Methods, 1992
- Suppression of natural killer cell activity by sera from patients with endometriosisAmerican Journal of Obstetrics and Gynecology, 1992
- Decreased Natural Killer Cell Activity in Women with EndometriosisGynecologic and Obstetric Investigation, 1992
- Etiology and epidemiology of endometriosisAmerican Journal of Obstetrics and Gynecology, 1990
- Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervixGynecologic Oncology, 1990
- Antitumor Actions of InterferonsInternational Journal of Dermatology, 1987
- Immunologic Aspects of Human EndometriosisAmerican Journal of Reproductive Immunology, 1984
- Deficient cellular immunity in endometriosisAmerican Journal of Obstetrics and Gynecology, 1981
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavityAmerican Journal of Obstetrics and Gynecology, 1927